MindPeak is an innovative start-up that builds diagnostic support tools for cancer diagnosis. Our Artificial Intelligence (AI) software analyses biopsy slides within seconds to find tumour regions and quantify tumour markers to pr...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SmartMammaCAD
Intelligent Automated System for detecting Diagnostically Ch...
257K€
Cerrado
TIN2009-13895-C02-01
AIDTUMOUR: HERRAMIENTAS BASADAS EN METODOS DE INTELIGENCIA A...
206K€
Cerrado
AI-PATH
Artificial intelligence expert to boost growth of a high pot...
100K€
Cerrado
DL-I-PBraTSC
Deep Learning Based Interpretable Pediatric Brain Tumors Seg...
Cerrado
BMAI
Empowering Radiologists in Cancer Diagnostics with Artificia...
4M€
Cerrado
AiforCancerDX
Deep learning AI in cancer diagnostics
3M€
Cerrado
Información proyecto AIPACA
Duración del proyecto: 24 meses
Fecha Inicio: 2020-07-03
Fecha Fin: 2022-07-31
Líder del proyecto
MINDPEAK GMBH
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
2M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
MindPeak is an innovative start-up that builds diagnostic support tools for cancer diagnosis. Our Artificial Intelligence (AI) software analyses biopsy slides within seconds to find tumour regions and quantify tumour markers to prepare them for visual inspection by the pathologist. In 2018, the number of diagnosed cancer cases has grown to 18 million globally.
Consequently, the demand for cancer diagnosis to determine appropriate treatment has never been higher. Cancer diagnosis nowadays is a very time-consuming process and depends heavily on the knowledge and experience of specialised pathologists. Unfortunately, the number of experts can no longer meet the quickly increasing demand. As a result, patients must wait longer than necessary for their diagnosis.
To overcome this challenge, MindPeak provides solutions based on deep learning to support pathologists in their diagnosis. Patients benefit from increased accuracy and a faster turn around time of diagnosis as well as reduced costs. The key USP of our AI is its reliability in the clinical context with its variations across and within labs. Funding from the EIC Accelerator will help us with a successful and fast go-to-market of our solutions that cover crucial improvements for cancer patients. With our technology, we address the market for pathology with a current size of $17.3 bn worldwide and an annual growth rate of 6.5%.